Details of the Drug Reposition

General Information of This Drug (ID: DMKYJJC)

Drug Name
Tigatuzumab   DMKYJJC
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colorectal cancer DISNH7P9 2B91.Z Phase 2 [1]
Pancreatic cancer DISJC981 2C10 Phase 2 [1]
Liver cancer DISDE4BI 2C12 Phase 2 [1]
Breast cancer DIS7DPX1 2C60-2C65 Phase 2 [1]
Ovarian cancer DISZJHAP 2C73 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01307891) Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer. U.S. National Institutes of Health.